CN1257510A - 具有器官保护活性的新的bpc肽盐,其制备方法及其在治疗中的应用 - Google Patents
具有器官保护活性的新的bpc肽盐,其制备方法及其在治疗中的应用 Download PDFInfo
- Publication number
- CN1257510A CN1257510A CN98805393A CN98805393A CN1257510A CN 1257510 A CN1257510 A CN 1257510A CN 98805393 A CN98805393 A CN 98805393A CN 98805393 A CN98805393 A CN 98805393A CN 1257510 A CN1257510 A CN 1257510A
- Authority
- CN
- China
- Prior art keywords
- pro
- nabpc157
- salt
- ala
- leu
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Gynecology & Obstetrics (AREA)
- Diabetes (AREA)
- Psychology (AREA)
- Pulmonology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
化合物 | pH值0.2%水溶液 | 0天 | 76天 | 120天 |
游离肽BPC157 | 4.46 | 99.3 | 98.1 | 97.4 |
肽BPC157单乙酸盐 | 4.53 | 99.2 | 97.8 | 95.3 |
BPC157的钠盐 | 6.51 | 99.4 | 99.5 | 99.4 |
BPC157的二钠盐 | 7.64 | 99.4 | 99.7 | 99.4 |
BPC157的TRIS盐 | 6.31 | 99.5 | 99.5 | 99.4 |
BPC157的二TRIS盐 | 8.24 | 99.5 | 99.5 | 99.5 |
BPC157的2-AMP盐 | 8.20 | 99.6 | 99.4 | 99.5 |
BPC157的TEAM盐 | 7.61 | 99.2 | 99.3 | 99.1 |
疾病 | 性别 | 刺激指数对照值≤2 |
消化性溃疡 | 女 | 26.82 |
多发性硬化 | 女 | 13.80 |
亚急性的sclerosans pancencephalitis | 女 | 2.54 |
视神经炎 | 男 | 3.54 |
视神经炎 | 女 | 9.53 |
眼色素层炎 | 女 | 16.87 |
眼色素层炎 | 男 | 15.21 |
眼色素层炎 | 女 | 22.30 |
血清反应阴性的脊椎关节病 | 女 | 4.99 |
遗传性嗜曙红细胞增多和大疱性皮炎 | 女 | 2.70 |
眼色素层炎 | 女 | 4.75 |
Claims (15)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97108384.5 | 1997-05-23 | ||
EP97108384 | 1997-05-23 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1257510A true CN1257510A (zh) | 2000-06-21 |
CN1166683C CN1166683C (zh) | 2004-09-15 |
Family
ID=8226822
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB988053934A Expired - Fee Related CN1166683C (zh) | 1997-05-23 | 1998-05-20 | 具有器官保护活性的新的bpc肽盐,其制备方法及其在治疗中的应用 |
Country Status (28)
Country | Link |
---|---|
US (1) | US6288028B1 (zh) |
EP (1) | EP0983300B1 (zh) |
JP (1) | JP3492381B2 (zh) |
KR (1) | KR100488038B1 (zh) |
CN (1) | CN1166683C (zh) |
AR (1) | AR011478A1 (zh) |
AT (1) | ATE277948T1 (zh) |
AU (1) | AU731317B2 (zh) |
BG (1) | BG64023B1 (zh) |
BR (1) | BR9809457B1 (zh) |
CA (1) | CA2290739C (zh) |
CZ (1) | CZ299423B6 (zh) |
DE (1) | DE69826653T2 (zh) |
DK (1) | DK0983300T3 (zh) |
EA (1) | EA002058B1 (zh) |
ES (1) | ES2229507T3 (zh) |
HU (1) | HU227800B1 (zh) |
ID (1) | ID23184A (zh) |
IL (2) | IL132884A0 (zh) |
NO (1) | NO321126B1 (zh) |
NZ (1) | NZ501323A (zh) |
PL (1) | PL193790B1 (zh) |
PT (1) | PT983300E (zh) |
RS (1) | RS49733B (zh) |
SK (1) | SK159599A3 (zh) |
TR (1) | TR199902866T2 (zh) |
UA (1) | UA61955C2 (zh) |
WO (1) | WO1998052973A1 (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11318191B2 (en) | 2020-02-18 | 2022-05-03 | Novo Nordisk A/S | GLP-1 compositions and uses thereof |
US11752198B2 (en) | 2017-08-24 | 2023-09-12 | Novo Nordisk A/S | GLP-1 compositions and uses thereof |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070160697A1 (en) * | 2004-02-27 | 2007-07-12 | Hiroshi Kobayashi | Cancer metastasis inhibitory composition |
US8022216B2 (en) * | 2007-10-17 | 2011-09-20 | Wyeth Llc | Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof |
SI24318A (sl) * | 2013-03-13 | 2014-09-30 | Diagen D.O.O. | Nove stabilne soli pentadekapeptida, postopek za njihovo pripravo, njihova uporaba za izdelavo farmacevtskih pripravkov in njihova uporaba v terapiji |
US10350293B2 (en) | 2016-08-23 | 2019-07-16 | Pharmacotherapia d.o.o. | Compositions and methods for treating symptoms associated with multiple sclerosis |
US11065298B1 (en) * | 2020-04-24 | 2021-07-20 | Chanda Zaveri | Compositions and methods for treating or preventing viral infections |
US11833189B1 (en) * | 2023-05-15 | 2023-12-05 | Red Mountain Med Spa, LLC | Sublingual Semaglutide-BPC 157 combination for weight loss |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU217541B (hu) * | 1990-09-11 | 2000-02-28 | Marko Duvnjak | Farmakológiailag hatásos BPC fehérje és eljárás ennek előállítására, valamint ezt tartalmazó gyógyszerkészítmény |
DE69219590T2 (de) * | 1992-05-30 | 1997-11-27 | Marko Duvnjak | BPC-Peptide, deren Herstellung und Verwendung |
CA2127553C (en) | 1992-11-16 | 2003-01-28 | Predrag Sikiric | Peptides with organo-protective activity, process for their preparation and their use in the therapy |
-
1998
- 1998-05-20 UA UA99127002A patent/UA61955C2/uk unknown
- 1998-05-20 US US09/424,414 patent/US6288028B1/en not_active Expired - Lifetime
- 1998-05-20 AU AU79141/98A patent/AU731317B2/en not_active Ceased
- 1998-05-20 NZ NZ501323A patent/NZ501323A/en not_active IP Right Cessation
- 1998-05-20 CA CA002290739A patent/CA2290739C/en not_active Expired - Fee Related
- 1998-05-20 KR KR10-1999-7010862A patent/KR100488038B1/ko not_active IP Right Cessation
- 1998-05-20 TR TR1999/02866T patent/TR199902866T2/xx unknown
- 1998-05-20 ID IDW991444A patent/ID23184A/id unknown
- 1998-05-20 RS YUP-601/99A patent/RS49733B/sr unknown
- 1998-05-20 WO PCT/EP1998/002953 patent/WO1998052973A1/en active IP Right Grant
- 1998-05-20 PL PL98336897A patent/PL193790B1/pl unknown
- 1998-05-20 CZ CZ0414299A patent/CZ299423B6/cs not_active IP Right Cessation
- 1998-05-20 HU HU0002329A patent/HU227800B1/hu not_active IP Right Cessation
- 1998-05-20 DK DK98929345T patent/DK0983300T3/da active
- 1998-05-20 IL IL13288498A patent/IL132884A0/xx active IP Right Grant
- 1998-05-20 SK SK1595-99A patent/SK159599A3/sk unknown
- 1998-05-20 DE DE69826653T patent/DE69826653T2/de not_active Expired - Lifetime
- 1998-05-20 EP EP98929345A patent/EP0983300B1/en not_active Expired - Lifetime
- 1998-05-20 EA EA199901061A patent/EA002058B1/ru not_active IP Right Cessation
- 1998-05-20 CN CNB988053934A patent/CN1166683C/zh not_active Expired - Fee Related
- 1998-05-20 ES ES98929345T patent/ES2229507T3/es not_active Expired - Lifetime
- 1998-05-20 BR BRPI9809457-2A patent/BR9809457B1/pt not_active IP Right Cessation
- 1998-05-20 PT PT98929345T patent/PT983300E/pt unknown
- 1998-05-20 AT AT98929345T patent/ATE277948T1/de active
- 1998-05-20 JP JP54994898A patent/JP3492381B2/ja not_active Expired - Fee Related
- 1998-05-26 AR ARP980102425A patent/AR011478A1/es active IP Right Grant
-
1999
- 1999-11-11 IL IL132884A patent/IL132884A/en not_active IP Right Cessation
- 1999-11-19 BG BG103905A patent/BG64023B1/bg unknown
- 1999-11-19 NO NO19995692A patent/NO321126B1/no not_active IP Right Cessation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11752198B2 (en) | 2017-08-24 | 2023-09-12 | Novo Nordisk A/S | GLP-1 compositions and uses thereof |
US11318191B2 (en) | 2020-02-18 | 2022-05-03 | Novo Nordisk A/S | GLP-1 compositions and uses thereof |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1137125C (zh) | 稠合的1,2,4-噻二嗪衍生物、其制备方法和用途 | |
US8318172B2 (en) | Breaking immunological tolerance with a genetically encoded unnatural amino acid | |
CN1309711C (zh) | 3-酰氨基-1,2-苯并异噁唑衍生物、其制备方法及应用 | |
CN1218802A (zh) | 取代的异喹啉-3-甲酰胺类化合物,其制备方法及其作为药物的用途 | |
CN1894275A (zh) | 模仿人epo的铰链核心模仿体、组合物、方法和用途 | |
CN1622830A (zh) | 肽基化合物 | |
CN1961000A (zh) | 具有可选择特性的杂合多肽 | |
CN1471538A (zh) | 用于竞争性调节二肽基肽酶iv催化的肽结构 | |
CN1147506A (zh) | 苯并氮䓬-苯并氧氮䓬-和苯并硫氮䓬-n-乙酸衍生物 | |
CN1138335A (zh) | 具有生长激素释放特性的化合物 | |
CN1331076A (zh) | 稠合的吡唑基化合物、包含该化合物的组合物及该化合物的应用 | |
CN1237978A (zh) | N-(芳基/杂芳基)氨基酸衍生物、包括这些衍生物的药用组合物以及用这些化合物抑制β-淀粉样肽释放和或其合成的方法 | |
CN101035806A (zh) | 新的糊精家族多肽-6(afp-6)类似物和制备和使用它们的方法 | |
WO2017157325A1 (zh) | 神经生长因子融合蛋白、制备方法及其用途 | |
CN1198747A (zh) | 作为金属蛋白酶和tnf释放抑制剂的硫取代的肽 | |
CN101080420A (zh) | 胸腺特异性蛋白质 | |
CN1426467A (zh) | 血栓生成素受体调节肽 | |
CN1166683C (zh) | 具有器官保护活性的新的bpc肽盐,其制备方法及其在治疗中的应用 | |
CN1304415C (zh) | 作为ace和nep抑制剂的吡喃衍生物 | |
CN1038103A (zh) | 环烷基取代的戊二酰胺利尿剂和其制备方法 | |
CN1173951C (zh) | 取代1,3-二芳基-2-吡啶-2-基-3-(吡啶-2-基氨基)-丙醇衍生物、其制备方法、含有它们的药物组合物及其应用 | |
CN1820025A (zh) | 荧光素标记的肽 | |
CN100345843C (zh) | 4-(硫代呫吨-9-亚基)-哌啶或吖啶的衍生物及其在制备药物中的应用 | |
CN1041366A (zh) | 具有t细胞抑制基因活性的肽的合成方法 | |
CN1127514C (zh) | 抗癌的肽类 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CI01 | Publication of corrected invention patent application |
Correction item: Inventor|Applicant Correct: Predrag Sikiric Marijan Peterc|Sven Sevels Blanco Tulkovic Zeljko Grabarryvik Ivo Roethke Vic Sepan Mise Marco Dunjak Ivan Udovisco False: Predrag Sikiric|Marijan Peterc Sven Sevels Blanco Tulkovic Zeljko Grabarryvik Number: 25 Page: 126 Volume: 16 |
|
CI02 | Correction of invention patent application |
Correction item: Inventor|Applicant Correct: Predrag Sikiric Marijan Peterc|Sven Sevels Blanco Tulkovic Zeljko Grabarryvik Ivo Roethke Vic Sepan Mise Marco Dunjak Ivan Udovisco False: Predrag Sikiric|Marijan Peterc Sven Sevels Blanco Tulkovic Zeljko Grabarryvik Number: 25 Page: The title page Volume: 16 |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: PREDRAG SIKIRIC MARIJAN PETEK SVEN SEIWERTH BLANCO PLANS ERKEWEIKE ZEERKE GRAPPARUIWEIKE TO: PREDRAG SIKIRIC MARIJAN PETEK SVEN SEIWERTH BLANCO PLANS ERKEWEIKE ZEERKE GRAPPARUIWEIKE LEVAN QINCHAZE YOUFU AIKEN NORMAN FRANKLIN DAQIEYI BARTLETT CHRISTOPHER JAMES Free format text: CORRECT: APPLICANT; FROM: PREDRAG SIKIRIC MARIJAN PETEK SVEN SEIWERTH BLANCO PLANS ERKEWEIKE ZEERKE GRAPPARUIWEIKE TO: PREDRAG SIKIRIC MARIJAN PETEK SVEN SEIWERTH BLANCO PLANS ERKEWEIKE ZEERKE GRAPPARUIWEIKE LEVAN QINCHAZE YOUFU AIKEN NORMAN FRANKLIN DAQIEYI BARTLETT CHRISTOPHER JAMES |
|
ERR | Gazette correction |
Free format text: CORRECT: INVENTOR; FROM: PREDRAG SIKIRIC MARIJAN PETEK SVEN SEIWERTH BLANCO PLANS ERKEWEIKE ZEERKE GRAPPARUIWEIKE TO: PREDRAG SIKIRIC MARIJAN PETEK SVEN SEIWERTH BLANCO PLANS ERKEWEIKE ZEERKE GRAPPARUIWEIKE LEVAN QINCHAZE YOUFU AIKEN NORMAN FRANKLIN DAQIEYI BARTLETT CHRISTOPHER JAMES Free format text: CORRECT: APPLICANT; FROM: PREDRAG SIKIRIC MARIJAN PETEK SVEN SEIWERTH BLANCO PLANS ERKEWEIKE ZEERKE GRAPPARUIWEIKE TO: PREDRAG SIKIRIC MARIJAN PETEK SVEN SEIWERTH BLANCO PLANS ERKEWEIKE ZEERKE GRAPPARUIWEIKE LEVAN QINCHAZE YOUFU AIKEN NORMAN FRANKLIN DAQIEYI BARTLETT CHRISTOPHER JAMES |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20040915 Termination date: 20170520 |
|
CF01 | Termination of patent right due to non-payment of annual fee |